Tapentadol in the management of cancer pain: current evidence and future perspectives.

J Pain Res · 2019 · PMC6526916 · PMID 31190966

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

When only those patients with a neuropathic pain component were analyzed, there was a tendency of higher response rate to tapentadol, which did not reach statistical significance in this relatively small sample, however.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.